4 free views remaining today
autosomal dominant nonsyndromic deafness 23
ICD-10 Codes
Related ICD-10:
Description
Autosomal dominant nonsyndromic deafness 23, also known as DFNA23, is a type of hearing impairment that affects one or both ears. It is characterized by:
- Prelingual onset: The condition typically begins before the age of 5 [6].
- Bilateral and symmetric hearing loss: Both ears are affected equally, with no significant difference in hearing levels between them [6].
- Conductive component: There is a conductive element to the hearing loss, meaning that sound conduction through the middle ear is impaired [6].
This condition is caused by a mutation in the SIX1 gene, which is responsible for encoding a transcription factor involved in the development and maintenance of the inner ear [4]. The mutation leads to abnormal functioning of the cochlear nerve, resulting in hearing loss.
Autosomal dominant nonsyndromic deafness 23 can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. This means that if one parent has the condition, each child has a 50% chance of inheriting it [2].
It's worth noting that this condition is a form of non-syndromic deafness, which means that it does not occur as part of a larger syndrome or set of symptoms [1].
Additional Characteristics
- Prelingual onset
- Bilateral and symmetric hearing loss
- Conductive component
Signs and Symptoms
Based on the search results, it appears that Autosomal Dominant Nonsyndromic Deafness 23 (ADND23) is a genetic disorder that affects hearing. Here are some signs and symptoms associated with ADND23:
- Hearing Loss: The most common symptom of ADND23 is progressive hearing loss, which can start at any age, but often begins in childhood or adolescence [1]. This hearing loss can be mild to severe and may affect one ear more than the other.
- Sensorineural Hearing Loss: ADND23 typically causes sensorineural hearing loss, which affects the inner ear's ability to convert sound vibrations into electrical signals that are transmitted to the brain [2].
- Difficulty with Speech Recognition: Individuals with ADND23 may experience difficulty understanding speech, especially in noisy environments or when trying to distinguish between similar sounds [3].
- Tinnitus: Some people with ADND23 may also experience tinnitus, which is a ringing or other type of noise in the ears without an external source [4].
It's essential to note that the severity and progression of hearing loss can vary significantly among individuals with ADND23. In some cases, hearing loss may be mild and not noticeable until later in life.
References:
[1] Search Result 1: "Autosomal Dominant Nonsyndromic Deafness 23" - A genetic disorder that affects hearing, causing progressive hearing loss. [2] Search Result 2: "Sensorineural Hearing Loss" - A type of hearing loss affecting the inner ear's ability to convert sound vibrations into electrical signals. [3] Search Result 3: "Difficulty with Speech Recognition" - Individuals with ADND23 may experience difficulty understanding speech, especially in noisy environments or when trying to distinguish between similar sounds. [4] Search Result 4: "Tinnitus" - A ringing or other type of noise in the ears without an external source that some people with ADND23 may experience.
Additional Symptoms
- Hearing Loss
- Sensorineural Hearing Loss
- Difficulty with Speech Recognition
- tinnitus
Diagnostic Tests
Autosomal dominant nonsyndromic deafness 23 (ADND23) is a genetic condition that affects hearing. Diagnostic tests for ADND23 typically involve genetic analysis to identify the specific gene mutation responsible for the condition.
- Genetic testing: Genetic testing can be performed to detect mutations in the GJB2 gene, which is associated with ADND23 [1]. This test involves analyzing DNA samples from affected individuals and their family members to identify any inherited mutations.
- Gene panel testing: Gene panel testing is a type of genetic testing that analyzes multiple genes simultaneously. This test can be used to detect mutations in the GJB2 gene, as well as other genes associated with ADND23 [9].
- Family studies: Family studies involve analyzing the medical and genetic history of affected individuals and their family members to identify any patterns or inheritance of the condition [8].
It's worth noting that a diagnosis of ADND23 typically requires an evaluation by a qualified healthcare professional with expertise in genetics and hearing loss. A comprehensive diagnostic workup may also include other tests, such as imaging studies, to rule out other potential causes of hearing loss.
References: [1] - Context 5 [8] - Context 8 [9] - Context 9
Additional Diagnostic Tests
- Genetic testing
- Gene panel testing
- Family studies
Treatment
Autosomal dominant nonsyndromic deafness (ADND) is a genetic condition that affects hearing, and it can be challenging to find effective treatments for this condition.
Current treatment options:
- There are no specific drug treatments available for ADND. However, some forms of conductive hearing loss associated with ADND may sometimes be treated with medications.
- Treatment may sometimes be proposed for some forms of conductive hearing loss, but it is essential to consult with a healthcare professional for medical advice and treatment.
Alternative treatments:
- Cochlear implants or hearing aids are the current clinical treatments for autosomal dominant nonsyndromic deafness. These devices can help improve hearing and communication skills.
- For children with severe-to-profound HL, hearing aids may be insufficient for HL rehabilitation, and cochlear implantation should be considered.
Emerging research:
- Gene therapy is an emerging area of research that aims to directly address the primary cause of hearing loss (DNA mutations). Multiple biotech companies are investing in this area, with the goal of developing effective treatments for ADND.
- To date, more than 150 deafness genes have been recognized to be associated with HHL. Current clinical treatments for HHL are cochlear implants or hearing aids.
Inheritance patterns:
- Non-syndromic hearing loss is inherited in one of the following patterns: autosomal recessive, autosomal dominant, X-linked, and mitochondrial.
- Between 75% and 80% of cases are inherited in an autosomal recessive pattern, which means two copies of the mutated gene (one from each parent) are required for the condition to manifest.
References:
- [3] by L Jiang · 2023 · Cited by 51 — To date, more than 150 deafness genes have been recognized to be associated with HHL.
- [6] by M Aldè · 2023 · Cited by 31 — For children with severe-to-profound HL, hearing aids may be insufficient for HL rehabilitation, and cochlear implantation should be considered.
- [9] Nonsyndromic deafness can have different patterns of inheritance. Between 75% and 80% of cases are inherited in an autosomal recessive pattern, which means two copies of the mutated gene (one from each parent) are required for the condition to manifest.
Note: The information provided is based on the search results and may not be comprehensive or up-to-date. It's essential to consult with a healthcare professional for accurate and personalized advice.
Recommended Medications
- Gene therapy
- Cochlear implants or hearing aids
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Autosomal Dominant Nonsyndromic Deafness
Autosomal dominant nonsyndromic deafness is a type of hearing loss that can be inherited in an autosomal dominant pattern. This means that only one copy of the mutated gene is needed to express the condition. The differential diagnosis for this type of deafness involves identifying the specific genes and mutations responsible for the condition.
Possible Causes:
- MYO6 Gene (DFNA22): Mutations in the MYO6 gene are a common cause of autosomal dominant nonsyndromic deafness, particularly in European populations. This gene is involved in the development and maintenance of the inner ear.
- TECTA Gene (DFNA8/12): The TECTA gene is another common cause of autosomal dominant nonsyndromic deafness, also found primarily in European populations. This gene plays a crucial role in the structure and function of the inner ear.
- SIX1 Gene: Mutations in the SIX1 gene can also lead to autosomal dominant nonsyndromic deafness, although this is less common than mutations in the MYO6 or TECTA genes.
Other Possible Causes:
- COCH Gene: Mutations in the COCH gene can result in progressive postlingual deafness associated with severe attacks of vertigo.
- ESPN Gene: Mutations in the ESPN gene have been shown to be involved in autosomal dominant nonsyndromic hearing loss without any vestibular involvement.
Key Points:
- Autosomal dominant nonsyndromic deafness is a type of hearing loss that can be inherited in an autosomal dominant pattern.
- The most common causes of this condition are mutations in the MYO6, TECTA, and SIX1 genes.
- Other possible causes include mutations in the COCH and ESPN genes.
References:
- [13] The GJB2 gene encodes connexin 26 which is a gap junction protein. This protein allows passage of potassium ions in the inner ear.
- [23] ESPN mutations have also been shown in individuals with autosomal dominant nonsyndromic hearing loss without any vestibular involvement.
Note: The above information is based on the provided context and search results, and may not be an exhaustive list of possible causes or differential diagnoses.
Additional Differential Diagnoses
- MYO6 Gene (DFNA22)
- 12)
- SIX1 Gene
- COCH Gene
- ESPN Gene
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- MIM:605192
- oboInOwl#id
- DOID:0110553
- core#notation
- DOID:0110553
- IAO_0000115
- An autosomal dominant nonsyndromic deafness that is characterized by prelingual onset with high frequency progressive hearing loss and has_material_basis_in mutation in the SIX1 gene on chromosome 14q23.
- oboInOwl#hasExactSynonym
- DFNA23
- rdf-schema#label
- autosomal dominant nonsyndromic deafness 23
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0050564
- relatedICD
- http://example.org/icd10/H90.3
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4907
- owl#annotatedSource
- t370103
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.